TCZ Masked Abdominal — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — TCZ suppresses CRP even in serious pathology; clinical assessment must drive management not inflammatory markers
The best answer is “TCZ suppresses CRP even in serious pathology; clinical assessment must drive management not inflammatory markers”. The full clinical pattern is most consistent with TCZ suppresses CRP even in serious pathology; clinical assessment must drive management not inflammatory markers; competing diagnoses share isolated features but not the decisive combination described. The remaining choices—“Low CRP reassuring on any biologic, after safety review, after specialist assessment, with clinical reassessment”, “Low CRP excludes pathology, after specialist assessment, with clinical reassessment, within a rheumatology pathway”, “CRP generally rises on TCZ, with clinical reassessment, within a rheumatology pathway, after safety review”, “principally ESR matters, after safety review, within a rheumatology pathway, after safety review, after specialist assessment”—are credible in related rheumatology presentations, but each addresses a different diagnosis, investigation, treatment sequence or complication and does not fit the decisive findings in this stem.
Reference: British Society for Rheumatology clinical guidelines: https://academic.oup.com/rheumatology/pages/clinical-guidelines